JP2014503593A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503593A5
JP2014503593A5 JP2013551354A JP2013551354A JP2014503593A5 JP 2014503593 A5 JP2014503593 A5 JP 2014503593A5 JP 2013551354 A JP2013551354 A JP 2013551354A JP 2013551354 A JP2013551354 A JP 2013551354A JP 2014503593 A5 JP2014503593 A5 JP 2014503593A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
subject
serum concentration
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013551354A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503593A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/022825 external-priority patent/WO2012103398A2/en
Publication of JP2014503593A publication Critical patent/JP2014503593A/ja
Publication of JP2014503593A5 publication Critical patent/JP2014503593A5/ja
Pending legal-status Critical Current

Links

JP2013551354A 2011-01-28 2012-01-27 閉塞性睡眠時無呼吸を処置するための方法 Pending JP2014503593A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161437272P 2011-01-28 2011-01-28
US61/437,272 2011-01-28
PCT/US2012/022825 WO2012103398A2 (en) 2011-01-28 2012-01-27 Methods for treating obstructive sleep apnea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017000145A Division JP6342525B2 (ja) 2011-01-28 2017-01-04 閉塞性睡眠時無呼吸を処置するための方法

Publications (2)

Publication Number Publication Date
JP2014503593A JP2014503593A (ja) 2014-02-13
JP2014503593A5 true JP2014503593A5 (enExample) 2015-03-19

Family

ID=46577943

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013551354A Pending JP2014503593A (ja) 2011-01-28 2012-01-27 閉塞性睡眠時無呼吸を処置するための方法
JP2017000145A Active JP6342525B2 (ja) 2011-01-28 2017-01-04 閉塞性睡眠時無呼吸を処置するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017000145A Active JP6342525B2 (ja) 2011-01-28 2017-01-04 閉塞性睡眠時無呼吸を処置するための方法

Country Status (6)

Country Link
US (2) US8753327B2 (enExample)
EP (1) EP2672972B1 (enExample)
JP (2) JP2014503593A (enExample)
CN (2) CN103458899A (enExample)
CA (1) CA2825309C (enExample)
WO (1) WO2012103398A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014503593A (ja) * 2011-01-28 2014-02-13 ファンタスティック・メディカル・リサーチ・インスティテュート・エルエルシー 閉塞性睡眠時無呼吸を処置するための方法
US20160361192A1 (en) * 2014-03-03 2016-12-15 Sleep Innovations Pty Ltd Device and method for sleep apnoea treatment
US10166268B2 (en) 2014-07-25 2019-01-01 The George Washington University Oxytocin improves treatment of obstructive sleep apnea
AU2016243801B2 (en) 2015-04-02 2020-05-21 Hill-Rom Services Pte. Ltd. Manifold for respiratory device
CN110198688B (zh) * 2016-12-23 2022-06-24 皇家飞利浦有限公司 用于处置至少两个用户间的打鼾的系统
GEAP202416602A (en) * 2017-04-28 2024-10-10 Brigham & Womens Hospital Inc Methods and compositions for treating sleep apnea
KR102874891B1 (ko) 2018-01-30 2025-10-21 애프니메드, 인코포레이티드 (델라웨어) 수면 무호흡증을 치료하기 위한 방법 및 조성물
EP3824881B1 (en) * 2018-06-18 2022-02-16 Amneal Complex Products Research LLC Extended release compositions comprising pyridostigmine
CN112601568B (zh) * 2018-08-24 2024-07-26 皇家飞利浦有限公司 利用压力治疗系统提供睡眠治疗
CN118557736A (zh) 2019-02-08 2024-08-30 布里格姆妇女医院 用于治疗睡眠呼吸暂停的方法和组合物
US20200282215A1 (en) 2019-03-06 2020-09-10 Medtronic Xomed, LLC Evaluating stimulation eficacy for treating sleep apnea and lingual muscle tone sensing system for improved osa therapy
CN114504643B (zh) * 2021-12-24 2024-03-26 北京大学第一医院 抗IgE抗体在用于治疗OSAS中的应用
EP4620390A1 (en) * 2022-12-28 2025-09-24 Nishikawa Co., Ltd. Health risk determination system, autonomic nerve determination system, life improvement system, sleeping posture determination system, sleeping posture determination program, bruxism detection system, and bruxism detection program
CN117402958A (zh) * 2023-10-26 2024-01-16 天津医科大学总医院 Claudin3及家族相关分子对阻塞性睡眠呼吸暂停低通气综合征的诊断价值

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2247662B (en) 1990-08-31 1994-11-02 Instance Ltd David J Labels and manufacture thereof
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
US7297691B2 (en) * 2003-08-13 2007-11-20 Janssen Pharmaceutica N.V. Treatment of sleep disorders with cholinesterase inhibitors
CN101291663A (zh) * 2005-09-16 2008-10-22 赛诺科学股份公司 预防和治疗睡眠呼吸障碍的方法和工具
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
JP2014503593A (ja) * 2011-01-28 2014-02-13 ファンタスティック・メディカル・リサーチ・インスティテュート・エルエルシー 閉塞性睡眠時無呼吸を処置するための方法

Similar Documents

Publication Publication Date Title
JP2014503593A5 (enExample)
JP2013509429A5 (enExample)
JP2012512907A5 (enExample)
JP2013525444A5 (enExample)
JP2013518107A5 (enExample)
CY1111500T1 (el) Οπιοειδη για τη θεραπεια χρονιας αποφρακτικης πνευμονοπαθειας (copd)
JP2015515475A5 (enExample)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
JP2014528474A5 (enExample)
JP2014505107A5 (enExample)
JP2006143751A5 (enExample)
BR112013031033A2 (pt) composição destinada ao tratamento de diabetes, compreendendo conjugado de insulina de ação prolongada e conjugado de peptídeo insulinotrópico de ação prolongada
JP2012193216A5 (enExample)
JP2014515351A5 (enExample)
JP2010518061A5 (enExample)
JP2012503668A5 (enExample)
JP2011527332A5 (enExample)
EA201401354A1 (ru) Новая дозированная форма и препарат, содержащий абедитерол
IL292465B1 (en) Neuroactive compounds and methods of using them
JP2011527333A5 (enExample)
JP2014532722A5 (enExample)
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2017500289A5 (enExample)
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
JP2013508289A5 (enExample)